These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24947936)

  • 1. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
    Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Dou K; Xu Q; Han X
    Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.
    Zhou L; Lu Y; Yang G; Wu J
    Tumour Biol; 2014 Feb; 35(2):1427-32. PubMed ID: 24277375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians.
    Ahmad Aizat AA; Siti Nurfatimah MS; Aminudin MM; Ankathil R
    World J Gastroenterol; 2013 Jun; 19(23):3623-8. PubMed ID: 23801864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
    Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
    Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
    He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
    Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of XPC Lys939Gln polymorphism and melanoma susceptibility.
    Jiang W; Zhang H; Chen QW; Xie S
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1327-31. PubMed ID: 26551988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
    Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
    J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
    Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
    PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
    Zhang Y; Wang X; Zhang W; Gong S
    Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
    Peng Q; Yang S; Lao X; Tang W; Chen Z; Lai H; Wang J; Sui J; Qin X; Li S
    PLoS One; 2014; 9(4):e94790. PubMed ID: 24733273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
    Zhu ML; Hua RX; Zheng L
    Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk.
    Mao D; Zhang Y; Lu H; Fu X
    Tumour Biol; 2013 Oct; 34(5):2529-38. PubMed ID: 23857281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in XPC gene and risk for prostate cancer.
    Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
    Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.